Sale disclosed
Well Daan Van
Chief Legal Officer
Ordinary Shares
- Reported value
- $50.1K
- Reported price
- $8.1226 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
SOPHiA GENETICS SA
Last 30 daysNo qualifying insider buying. Sales: $912.77K by 10 insiders.
Showing the first 6 of 200 trades on this page.
Chief Legal Officer
Ordinary Shares
Chief People Officer
Ordinary Shares
Chief Technology Officer
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Financial Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Executive Chairman
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Financial Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Legal Officer
Ordinary Shares
Executive Chairman
Ordinary Shares
Director
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Director
Ordinary Shares
Chief Technology Officer
Ordinary Shares
Chief Technology Officer
Ordinary Shares
Chief People Officer
Ordinary Shares
Chief People Officer
Ordinary Shares
Chief People Officer
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Technology Officer
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Scientific Officer
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Technology Officer
Ordinary Shares
Executive Chairman
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Medical Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Chief Financial Officer
Ordinary Shares
Chief People Officer
Ordinary Shares
Chief Technology Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Ordinary Shares
Executive Chairman
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Executive Chairman
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Technology Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Financial Officer
Ordinary Shares
President
Ordinary Shares
Director
Ordinary Shares
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
Director
Ordinary Shares
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
Director
Ordinary Shares
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
Director
Ordinary Shares
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
Director
Ordinary Shares
Director
Share Option (Right to Buy)
Derivative security · not the ordinary share price.
Chief Scientific Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Financial Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
President
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Legal Officer
Ordinary Shares
Chief People Officer
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Director
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief People Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Legal Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
President
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
President
Ordinary Shares
Chief Legal Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
President
Ordinary Shares
President
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
President
Ordinary Shares
President
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief People Officer
Ordinary Shares
Chief Legal Officer
Ordinary Shares
Chief Legal Officer
Ordinary Shares
Chief Financial Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Medical Officer
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Sales Officer
Ordinary Shares
Chief Legal Officer
Ordinary Shares
Chief Legal Officer
Ordinary Shares
President
Ordinary Shares
President
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Executive Officer
Ordinary Shares
Chief Financial Officer
Ordinary Shares
Chief Financial Officer
Ordinary Shares
Chief People Officer
Ordinary Shares
Chief People Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Scientific Officer
Ordinary Shares
Chief Technology Officer
Ordinary Shares
Chief Technology Officer
Ordinary Shares
Chief Legal Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Financial Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Financial Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Sales Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Sales Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief People Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief People Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Scientific Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Scientific Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Technology Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Technology Officer
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Technology Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Technology Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Scientific Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Scientific Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Sales Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Sales Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Financial Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Financial Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief People Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief People Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Ordinary Shares
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Share Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Sales Officer
Ordinary Shares
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Legal Officer | Ordinary SharesSale10b5-1 | 6,168$8.12 / share | $50.1K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief People Officer | Ordinary SharesSale10b5-1 | 4,240$8.13 / share | $34.49K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Technology Officer | Ordinary SharesSale10b5-1 | 5,284$8.12 / share | $42.93K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Sales Officer | Ordinary SharesSale2 trades | 216avg $8.04 / share | $1.74K | Oct 5Filed Oct 7 · 2d later | 2 filings
|
| Chief Financial Officer | Ordinary SharesSale10b5-1 | 1,592$8.10 / share | $12.9K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 7,394$8.13 / share | $60.1K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 40,172$8.13 / share | $326.53K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 7,394$8.12 / share | $60.07K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 9,838$8.13 / share | $79.97K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Financial Officer | Ordinary SharesSale10b5-1 | 774$8.33 / share | $6.45K | Sep 21Filed Sep 22 · 1d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 422$8.33 / share | $3.52K | Sep 21Filed Sep 22 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$7.88 / share | $39.42K | Sep 14Filed Sep 16 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 4,000$7.88 / share | $31.54K | Sep 14Filed Sep 16 · 2d later | SEC filing |
| Chief Legal Officer | Ordinary SharesSale10b5-1 | 6,168$7.63 / share | $47.09K | Sep 11Filed Sep 14 · 3d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 8,500$7.66 / share | $65.12K | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Ordinary SharesSale10b5-1 | 6,250$8.13 / share | $50.82K | Sep 8Filed Sep 10 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 10,000$8.91 / share | $89.1K | Aug 27Filed Aug 31 · 4d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$8.68 / share | $43.4K | Aug 25Filed Aug 26 · 1d later | SEC filing |
| Director | Ordinary SharesSale10b5-1 | 6,250$8.68 / share | $54.23K | Aug 25Filed Aug 26 · 1d later | SEC filing |
| Chief Technology Officer | Ordinary SharesSale10b5-1 | 5,000$8.20 / share | $41K | Aug 19Filed Aug 26 · 7d later | SEC filing |
| Chief Technology Officer | Ordinary SharesSale10b5-1 | 5,000$8.80 / share | $44K | Aug 24Filed Aug 26 · 2d later | SEC filing |
| Chief People Officer | Ordinary SharesOption exercise or conversion10b5-1 | 10,000$3.20 / share | $32K | Aug 19Filed Aug 21 · 2d later | SEC filing |
| Chief People Officer | Ordinary SharesSale10b5-1 | 10,000$7.94 / share | $79.44K | Aug 19Filed Aug 21 · 2d later | SEC filing |
| Chief People Officer | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units10,000$3.20 exercise / conversion price | Not a separate purchase | Aug 19Filed Aug 21 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 10,000$7.94 / share | $79.43K | Aug 19Filed Aug 21 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 4,592$8.41 / share | $38.61K | Aug 20Filed Aug 21 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 5,408$8.40 / share | $45.45K | Aug 21Filed Aug 21 · 0d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$7.52 / share | $37.58K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 4,000$7.52 / share | $30.08K | Aug 13Filed Aug 14 · 1d later | SEC filing |
| Chief Technology Officer | Ordinary SharesSale10b5-1 | 5,000$7.60 / share | $38K | Aug 7Filed Aug 10 · 3d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 20,000$7.23 / share | $144.54K | Aug 7Filed Aug 10 · 3d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 8,500$7.61 / share | $64.67K | Aug 10Filed Aug 10 · 0d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesOption exercise or conversion10b5-1 | 3,000$3.28 / share | $9.84K | Aug 5Filed Aug 7 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 3,000$7.00 / share | $21.01K | Aug 5Filed Aug 7 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesOption exercise or conversion10b5-1 | 7,000$3.28 / share | $22.96K | Aug 7Filed Aug 7 · 0d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-12 trades | 17,000avg $7.29 / share | $123.91K | Aug 7Filed Aug 7 · 0d later | 2 filings
|
| Chief Scientific Officer | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units3,000$3.28 exercise / conversion price | Not a separate purchase | Aug 5Filed Aug 7 · 2d later | SEC filing |
| Chief Scientific Officer | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units7,000$3.28 exercise / conversion price | Not a separate purchase | Aug 7Filed Aug 7 · 0d later | SEC filing |
| Chief Technology Officer | Ordinary SharesSale10b5-1 | 5,000$6.95 / share | $34.77K | Aug 4Filed Aug 5 · 1d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 20,000$6.92 / share | $138.41K | Aug 4Filed Aug 5 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 10,000$6.92 / share | $69.17K | Aug 4Filed Aug 5 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$5.66 / share | $28.31K | Jul 27Filed Jul 28 · 1d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 19,800$6.32 / share | $125.2K | Jul 20Filed Jul 22 · 2d later | SEC filing |
| Executive Chairman | Ordinary SharesOption exercise or conversion10b5-1 | 4,581$3.16 / share | $14.48K | Jul 20Filed Jul 22 · 2d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 4,581$6.17 / share | $28.24K | Jul 20Filed Jul 22 · 2d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 20,000$6.63 / share | $132.65K | Jul 21Filed Jul 22 · 1d later | SEC filing |
| Executive Chairman | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units4,581$3.16 exercise / conversion price | Not a separate purchase | Jul 20Filed Jul 22 · 2d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$5.70 / share | $28.51K | Jul 13Filed Jul 14 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 4,000$5.70 / share | $22.82K | Jul 13Filed Jul 14 · 1d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 8,500$5.62 / share | $47.79K | Jul 10Filed Jul 14 · 4d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 17,685$5.28 / share | $93.33K | Jul 7Filed Jul 8 · 1d later | SEC filing |
| Chief Financial Officer | Ordinary SharesSale10b5-1 | 1,592$5.29 / share | $8.42K | Jul 6Filed Jul 7 · 1d later | SEC filing |
| Chief People Officer | Ordinary SharesSale10b5-1 | 4,241$5.05 / share | $21.43K | Jul 6Filed Jul 7 · 1d later | SEC filing |
| Chief Technology Officer | Ordinary SharesSale10b5-1 | 5,285$5.10 / share | $26.96K | Jul 6Filed Jul 7 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 7,393$5.17 / share | $38.24K | Jul 6Filed Jul 7 · 1d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 9,838$5.22 / share | $51.35K | Jul 6Filed Jul 7 · 1d later | SEC filing |
| Chief Sales Officer | Ordinary SharesSale3 trades | 216avg $5.03 / share | $1.09K | Jul 6Filed Jul 7 · 1d later | 3 filings
|
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 7,393$5.16 / share | $38.16K | Jul 6Filed Jul 7 · 1d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-1 | 22,486$5.26 / share | $118.16K | Jul 6Filed Jul 7 · 1d later | SEC filing |
| Executive Chairman | Ordinary SharesOption exercise or conversion10b5-1 | 18,060$3.16 / share | $57.07K | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-12 trades | 18,410avg $5.87 / share | $108.06K | Jun 29Filed Jul 1 · 2d later | 2 filings
|
| Executive Chairman | Ordinary SharesOption exercise or conversion10b5-1 | 45,419$3.16 / share | $143.52K | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Executive Chairman | Ordinary SharesSale10b5-13 trades | 65,269avg $6.11 / share | $398.63K | Jun 30Filed Jul 1 · 1d later | 3 filings
|
| Executive Chairman | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units18,060$3.16 exercise / conversion price | Not a separate purchase | Jun 29Filed Jul 1 · 2d later | SEC filing |
| Executive Chairman | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units45,419$3.16 exercise / conversion price | Not a separate purchase | Jun 30Filed Jul 1 · 1d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 1,373$5.70 / share | $7.83K | Jun 25Filed Jun 29 · 4d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 18,129$5.73 / share | $103.93K | Jun 26Filed Jun 29 · 3d later | SEC filing |
| Chief Executive Officer | Ordinary SharesOption exercise or conversion10b5-1 | 31,940$3.16 / share | $100.93K | Jun 26Filed Jun 29 · 3d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 31,940$5.84 / share | $186.4K | Jun 26Filed Jun 29 · 3d later | SEC filing |
| Chief Executive Officer | Share Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units31,940$3.16 exercise / conversion price | Not a separate purchase | Jun 26Filed Jun 29 · 3d later | SEC filing |
| Chief Technology Officer | Ordinary SharesSale10b5-1 | 6,944$5.51 / share | $38.23K | Jun 25Filed Jun 26 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$5.50 / share | $27.52K | Jun 25Filed Jun 26 · 1d later | SEC filing |
| Chief Financial Officer | Ordinary SharesSale10b5-1 | 774$5.38 / share | $4.16K | Jun 22Filed Jun 23 · 1d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 422$5.38 / share | $2.27K | Jun 22Filed Jun 23 · 1d later | SEC filing |
| Director | Ordinary SharesGrant or award | 19,724$5.46 / share | $107.69K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units28,818$5.46 / derivative unit | $157.35K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Ordinary SharesGrant or award | 19,724$5.46 / share | $107.69K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units28,818$5.46 / derivative unit | $157.35K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Ordinary SharesGrant or award | 19,724$5.46 / share | $107.69K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units28,818$5.46 / derivative unit | $157.35K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Ordinary SharesGrant or award | 19,724$5.46 / share | $107.69K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units28,818$5.46 / derivative unit | $157.35K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Ordinary SharesGrant or award | 19,724$5.46 / share | $107.69K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Director | Share Option (Right to Buy)Grant or award | Derivative units28,818$5.46 / derivative unit | $157.35K | Jun 18Filed Jun 22 · 4d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 4,000$5.01 / share | $20.06K | Jun 15Filed Jun 17 · 2d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$4.95 / share | $24.75K | Jun 12Filed Jun 15 · 3d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 8,500$5.24 / share | $44.5K | Jun 10Filed Jun 11 · 1d later | SEC filing |
| Chief Financial Officer | Ordinary SharesPurchase | 20,000$4.95 / share | $99K | Jun 5Filed Jun 5 · 0d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$4.95 / share | $24.77K | May 26Filed Jun 1 · 6d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 761$4.60 / share | $3.5K | May 19Filed May 20 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 608$4.60 / share | $2.8K | May 19Filed May 20 · 1d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 4,486$4.60 / share | $20.66K | May 19Filed May 20 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 608$4.61 / share | $2.8K | May 19Filed May 20 · 1d later | SEC filing |
| Chief Legal Officer | Ordinary SharesSale10b5-1 | 684$4.60 / share | $3.15K | May 19Filed May 20 · 1d later | SEC filing |
| Chief People Officer | Ordinary SharesSale10b5-1 | 380$4.60 / share | $1.75K | May 19Filed May 20 · 1d later | SEC filing |
| Chief Sales Officer | Ordinary SharesSale | 33$4.54 / share | $149.9 | May 19Filed May 20 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 4,000$4.54 / share | $18.17K | May 13Filed May 14 · 1d later | SEC filing |
| Director | Ordinary SharesSale10b5-1 | 7,508$4.67 / share | $35.04K | May 12Filed May 13 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$4.67 / share | $23.34K | May 12Filed May 13 · 1d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 8,500$5.09 / share | $43.24K | May 11Filed May 12 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 5,000$4.82 / share | $24.09K | Apr 27Filed Apr 28 · 1d later | SEC filing |
| Chief People Officer | Ordinary SharesSale10b5-1 | 380$5.20 / share | $1.98K | Apr 20Filed Apr 21 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 608$5.21 / share | $3.16K | Apr 20Filed Apr 21 · 1d later | SEC filing |
| Chief Legal Officer | Ordinary SharesSale10b5-1 | 684$5.20 / share | $3.55K | Apr 20Filed Apr 21 · 1d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 4,486$5.21 / share | $23.35K | Apr 20Filed Apr 21 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 608$5.20 / share | $3.16K | Apr 20Filed Apr 21 · 1d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 760$5.20 / share | $3.95K | Apr 20Filed Apr 21 · 1d later | SEC filing |
| Chief Sales Officer | Ordinary SharesSale | 33$5.08 / share | $167.69 | Apr 20Filed Apr 21 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 600$4.97 / share | $2.98K | Apr 14Filed Apr 16 · 2d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 43,129$4.96 / share | $213.83K | Apr 14Filed Apr 16 · 2d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 17,473$5.00 / share | $87.4K | Apr 15Filed Apr 16 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 1,600$4.96 / share | $7.93K | Apr 14Filed Apr 16 · 2d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 2,800$4.96 / share | $13.89K | Apr 14Filed Apr 16 · 2d later | SEC filing |
| Chief Legal Officer | Ordinary SharesSale10b5-1 | 2,400$4.67 / share | $11.2K | Apr 10Filed Apr 14 · 4d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 3,706$4.68 / share | $17.35K | Apr 10Filed Apr 14 · 4d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-12 trades | 4,414avg $4.76 / share | $21.03K | Apr 13Filed Apr 14 · 1d later | 2 filings
|
| Chief Executive Officer | Ordinary SharesSale10b5-12 trades | 12,232avg $4.72 / share | $57.71K | Apr 10Filed Apr 14 · 4d later | 2 filings
|
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 4,399$4.76 / share | $20.96K | Apr 13Filed Apr 14 · 1d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 3,687$4.69 / share | $17.28K | Apr 10Filed Apr 14 · 4d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 4,442$4.77 / share | $21.17K | Apr 13Filed Apr 14 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 3,725$4.68 / share | $17.44K | Apr 10Filed Apr 14 · 4d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-12 trades | 4,400avg $4.76 / share | $20.96K | Apr 13Filed Apr 14 · 1d later | 2 filings
|
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 2,800$4.84 / share | $13.55K | Apr 8Filed Apr 10 · 2d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 1,950$4.74 / share | $9.24K | Apr 9Filed Apr 10 · 1d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 2,786$4.84 / share | $13.49K | Apr 8Filed Apr 10 · 2d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 1,950$4.74 / share | $9.24K | Apr 9Filed Apr 10 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 2,800$4.84 / share | $13.55K | Apr 8Filed Apr 10 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 1,936$4.74 / share | $9.18K | Apr 9Filed Apr 10 · 1d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 2,800$4.84 / share | $13.54K | Apr 8Filed Apr 10 · 2d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 1,931$4.74 / share | $9.15K | Apr 9Filed Apr 10 · 1d later | SEC filing |
| Chief People Officer | Ordinary SharesSale10b5-1 | 3,824$4.85 / share | $18.54K | Apr 8Filed Apr 10 · 2d later | SEC filing |
| Chief Legal Officer | Ordinary SharesSale10b5-1 | 2,861$4.85 / share | $13.86K | Apr 8Filed Apr 10 · 2d later | SEC filing |
| Chief Legal Officer | Ordinary SharesSale10b5-1 | 1,988$4.74 / share | $9.42K | Apr 9Filed Apr 10 · 1d later | SEC filing |
| Chief Financial Officer | Ordinary SharesSale10b5-1 | 1,403$4.85 / share | $6.8K | Apr 8Filed Apr 10 · 2d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 2,700$4.85 / share | $13.1K | Apr 6Filed Apr 8 · 2d later | SEC filing |
| Chief Medical Officer | Ordinary SharesSale10b5-1 | 2,400$4.87 / share | $11.68K | Apr 7Filed Apr 8 · 1d later | SEC filing |
| Chief Sales Officer | Ordinary SharesSale3 trades | 624avg $4.86 / share | $3.03K | Apr 6Filed Apr 8 · 2d later | 3 filings
|
| Chief Legal Officer | Ordinary SharesSale10b5-1 | 2,705$4.86 / share | $13.14K | Apr 6Filed Apr 8 · 2d later | SEC filing |
| Chief Legal Officer | Ordinary SharesSale10b5-1 | 2,400$4.87 / share | $11.68K | Apr 7Filed Apr 8 · 1d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 2,600$4.85 / share | $12.6K | Apr 6Filed Apr 8 · 2d later | SEC filing |
| President | Ordinary SharesSale10b5-1 | 2,424$4.87 / share | $11.8K | Apr 7Filed Apr 8 · 1d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 2,600$4.85 / share | $12.61K | Apr 6Filed Apr 8 · 2d later | SEC filing |
| Chief Executive Officer | Ordinary SharesSale10b5-1 | 2,500$4.86 / share | $12.15K | Apr 7Filed Apr 8 · 1d later | SEC filing |
| Chief Financial Officer | Ordinary SharesSale10b5-1 | 2,520$4.85 / share | $12.21K | Apr 6Filed Apr 8 · 2d later | SEC filing |
| Chief Financial Officer | Ordinary SharesSale10b5-1 | 2,413$4.88 / share | $11.77K | Apr 7Filed Apr 8 · 1d later | SEC filing |
| Chief People Officer | Ordinary SharesSale10b5-1 | 2,597$4.85 / share | $12.58K | Apr 6Filed Apr 8 · 2d later | SEC filing |
| Chief People Officer | Ordinary SharesSale10b5-1 | 2,376$4.87 / share | $11.57K | Apr 7Filed Apr 8 · 1d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 2,700$4.85 / share | $13.1K | Apr 6Filed Apr 8 · 2d later | SEC filing |
| Chief Scientific Officer | Ordinary SharesSale10b5-1 | 2,400$4.87 / share | $11.68K | Apr 7Filed Apr 8 · 1d later | SEC filing |
| Chief Technology Officer | Ordinary SharesSale10b5-1 | 2,519$4.86 / share | $12.24K | Apr 6Filed Apr 8 · 2d later | SEC filing |
| Chief Technology Officer | Ordinary SharesSale10b5-1 | 1,030$4.87 / share | $5.02K | Apr 7Filed Apr 8 · 1d later | SEC filing |
Chief Legal OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Ordinary SharesGrant or award | 97,536Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Legal OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units142,216Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
PresidentAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Ordinary SharesGrant or award | 431,211Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
PresidentAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units628,743Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Financial OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Ordinary SharesGrant or award | 112,936Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Financial OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units164,671Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Executive OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Ordinary SharesGrant or award | 431,211Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Executive OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units628,743Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Medical OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Ordinary SharesGrant or award | 112,936Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Medical OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units164,671Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Sales OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Ordinary SharesGrant or award | 56,468Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Sales OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units82,335Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief People OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Ordinary SharesGrant or award | 71,869Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief People OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units104,790Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Scientific OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Ordinary SharesGrant or award | 112,936Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Scientific OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units164,671Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Technology OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Ordinary SharesGrant or award | 82,136Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Technology OfficerAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units119,760Award · no purchase price | Non-cash award | Apr 2Filed Apr 8 · 6d later | SEC filing |
Chief Technology OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Ordinary SharesGrant or award | 82,136Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Technology OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units119,760Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
PresidentSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Ordinary SharesGrant or award | 431,211Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
PresidentSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units628,743Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Medical OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Ordinary SharesGrant or award | 112,936Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Medical OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units164,671Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Scientific OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Ordinary SharesGrant or award | 112,936Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Scientific OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units164,671Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Executive OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Ordinary SharesGrant or award | 431,211Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Executive OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units628,743Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Sales OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Ordinary SharesGrant or award | 56,468Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Sales OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units82,335Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Financial OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Ordinary SharesGrant or award | 112,936Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Financial OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units164,671Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief People OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Ordinary SharesGrant or award | 71,869Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief People OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units104,790Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Legal OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Ordinary SharesGrant or award | 97,536Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
Chief Legal OfficerSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Share Option (Right to Buy)Grant or award | Derivative units142,216Award · no purchase price | Non-cash award | Apr 2Filed Apr 3 · 1d later | SEC filing |
| Chief Sales Officer | Ordinary SharesSale | 3$4.71 / share | $14.13 | Mar 31Filed Apr 1 · 1d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
$24,750 of common-equity purchase value after transaction-age decay across 180 days.
1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
Qualifying common-equity P acquisition; no disclosed plan, exercise or excluded purchase context detected.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.